<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00953563</url>
  </required_header>
  <id_info>
    <org_study_id>U0802</org_study_id>
    <nct_id>NCT00953563</nct_id>
  </id_info>
  <brief_title>The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers</brief_title>
  <official_title>The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Synovis Surgical Innovations</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Baxter Healthcare Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the mechanism of action of the Unite Biomatrix and
      compare its performance with the standard of care, compression therapy alone for the
      treatment of venous leg ulcers.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Budgetary
  </why_stopped>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">July 2011</completion_date>
  <primary_completion_date type="Anticipated">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound healing pathway markers</measure>
    <time_frame>baseline, day 0, 3, wk 1, 2</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bacterial Bioburder</measure>
    <time_frame>baseline, day 0, 3, wk 1, 2</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Venous Leg Ulcers</condition>
  <arm_group>
    <arm_group_label>compression therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Biologic with compression therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Unite Biomatrix</intervention_name>
    <description>collagen based, decellularized equine pericardial dressing for skin surface wounds</description>
    <arm_group_label>Biologic with compression therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  venous ulcer confirmed w/ duplex ultrasound

          -  ulcer greater than 6 months duration

          -  post-debridement, the ulcer size must be &gt;5cm2

          -  at least 18 years old

          -  ABI is between 0.7 to 1.2 and/or one of the following:

               -  TcPO2 &gt; 30mmHg at the ankle

               -  Doppler waveform consistent with adequate flow in the foot (biphasic or
                  triphasic)

          -  able and willing to provide a voluntary written informed consent

          -  three or fewer ulcers separated by &gt;3.0 cm distance

          -  able and willing to attend scheduled follow-up visits and study related exams

        Exclusion Criteria:

          -  greater than 20% reduction in wound size during the first 2 weeks of observation with
             the investigator

          -  ulcer with exposed bone or tendon

          -  clinical infection at the studied ulcer site including cellulitis and osteomyelitis

          -  ulcer of a non-venous insufficiency etiology

          -  phlebitis or deep leg vein thrombosis in past 30 days

          -  arterial bypass in previous 30 days

          -  severe anemia (Hgb&lt;8)

          -  serum albumin &lt;3.0

          -  uncompensated congestive heart failure

          -  renal failure with Creatinine &gt;2.5mg/dl

          -  rheumatoid arthritis (and other collagen vascular disease), vasculitis, sickle cell
             disease, HIV

          -  severe liver disease as defined by treating physician

          -  uncontrolled diabetes mellitus determined by treating physician

          -  malignancy at or near the ulcer site

          -  any condition judged by the PI that would cause the study to be detrimental to the
             patient

          -  known allergy to equine derived tissue

          -  received another investigational device or drug within 30 days of Day 0

          -  radiation therapy at the wound site

          -  chemotherapy or immunosuppressive therapy within 30 days of enrollment

          -  received another allograft, autograft, xenograft within 30 days of the study

          -  pregnant or nursing women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerit Mulder, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSD Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami, Miller School of Medicine</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newbridge Medical Research Corp., Warren General Hosp.</name>
      <address>
        <city>Warren</city>
        <state>Pennsylvania</state>
        <zip>16365</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2009</study_first_submitted>
  <study_first_submitted_qc>August 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2009</study_first_posted>
  <last_update_submitted>April 4, 2017</last_update_submitted>
  <last_update_submitted_qc>April 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Venous Leg Ulcers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

